| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07e4ae480907e93fdfb97156489e7117 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate |
2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cbb2c7deb4c991215a1e9a1ed571cbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1864d80595fbd5539d20e126f303944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f5e6b4bf88214a21ec57b1c9ed1fa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb8791011386925121f342e84b3308f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f86b0564e9a8c2bb86e4cdf0394faac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a68c061dc25ff6155192d67b30d09bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f9014573d11f7e0bc06ffb1b368cac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32e267260c67e2c0c1c3fc4f61bf40e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5113e57d13d3b495b535c66444c8c78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef70710664c13ba4067df8db9a6982e |
| publicationDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102264381-B |
| titleOfInvention |
A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| abstract |
Disclosed are immunogenic conjugates which elicit an immune response to Plasmodium proteins. In particular examples, the Plasmodium proteins include sexual stage surface proteins, circumsporozoite protein (CSP), or immunogenic portions of CSP. Also provided herein are immunogenic compositions including one or more of the disclosed immunogenic conjugates and a pharmaceutically acceptable carrier. Further provided is a method of eliciting an immune response to Plasmodium in a subject, comprising administering to the subject an immunogenic composition disclosed herein. |
| priorityDate |
2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |